Cargando…

Determination of Biological Activity of Recombinant Reteplase Using Clot Lysis Time and Activated Partial Thromboplastin Time (APTT) Lysis Methods: A Comparative Study

Recombinant plasminogen activator (reteplase) is a third generation thrombolytic agent which has been used on coronary artery thrombosis and acute myocardial infarction. Clot lysis assay is usually considered as a unique method to evaluate biological activity of reteplase. In this study biological a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Babaee, Tahereh, Fazeli, Ahmad, Hashemi-Najafabadi, Sameereh, Rastegar, Hosein, Mohammadi, Ali, Khoshayand, Mohammad Reza, Alebouyeh, Mahmoud, Fazeli, Mohammad Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shaheed Beheshti University of Medical Sciences 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269549/ https://www.ncbi.nlm.nih.gov/pubmed/30568707

Ejemplares similares

Improvement of Soluble Production of Reteplase in Escherichia coli by Optimization of Chemical Chaperones in Lysis Buffer
por: Fazeli, Behnaz, et al.
Publicado: (2019)

A new device for measurement of fibrin clot lysis: application to the Euglobulin Clot Lysis Time
por: Boudjeltia, K Zouaoui, et al.
Publicado: (2002)

Influence of factor XII deficiency on activated partial thromboplastin time (aPTT) in critically ill patients
por: Bachler, Mirjam, et al.
Publicado: (2019)

Reporting of activated partial thromboplastin time (aPTT): Could we achieve better comparability of the results?
por: Bronić, Ana, et al.
Publicado: (2021)

An Unusual Etiology for Elevation of Activated Partial Thromboplastin Time (aPTT) in SLE: Acquired Hemophilia and Lupus Anticoagulant
por: Seethala, Srikanth, et al.
Publicado: (2013)

Fibrin Clot Formation and Lysis in Plasma
por: Larsen, Julie Brogaard, et al.
Publicado: (2020)

Prediction of Poor Outcomes in Patients with Colorectal Cancer: Elevated Preoperative Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT)
por: Zhang, Lin, et al.
Publicado: (2020)

Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone
por: Härdig, Bjarne Madsen, et al.
Publicado: (2008)

Congruent identification of imbalanced fibrinolysis by 2 distinct clot lysis time assays
por: Driever, Ellen G., et al.
Publicado: (2023)

Development of an in vitro model to study clot lysis activity of thrombolytic drugs
por: Prasad, Sweta, et al.
Publicado: (2006)

Prediction of Recurrent Venous Thromboembolism by Clot Lysis Time: A Prospective Cohort Study
por: Traby, Ludwig, et al.
Publicado: (2012)

Plasma Clot Lysis Time and Its Association with Cardiovascular Risk Factors in Black Africans
por: de Lange, Zelda, et al.
Publicado: (2012)

Biological Activity Analysis of Native and Recombinant Streptokinase Using Clot Lysis and Chromogenic Substrate Assay
por: Mahboubi, Arash, et al.
Publicado: (2012)

Properties of Plasma Clots in Adult Patients Following Fontan Procedure: Relation to Clot Permeability and Lysis Time—Multicenter Study
por: Skubera, Maciej, et al.
Publicado: (2021)

Reduced fibrin clot lysis in Klinefelter syndrome associated with hypogonadism
por: Chang, Simon, et al.
Publicado: (2022)

SUN-085 Assessing the Impact of Disease Activity on Clot Formation and Lysis in Patients with Acromegaly
por: Kyriakakis, Nikolaos, et al.
Publicado: (2019)

Optimization of Chitinase Production by Bacillus pumilus Using Plackett-Burman Design and Response Surface Methodology
por: Tasharrofi, Noshin, et al.
Publicado: (2011)

Reagent Effects on the Activated Partial Thromboplastin Time Clot Waveform Analysis: A Multi-Centre Study
por: Wong, Wan Hui, et al.
Publicado: (2023)

THE LYSIS IN RABBITS OF INTRAVASCULAR BLOOD CLOTS BY THE STREPTOCOCCAL FIBRINOLYTIC SYSTEM (STREPTOKINASE)
por: Johnson, Alan J., et al.
Publicado: (1952)

Clot Lysis and Antimitotic Study of Ficus glomerata Roxb Fruit Extracts
por: Shivasharanappa, Kirankumar, et al.
Publicado: (2014)

The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis Profile
por: Bollen, Lize, et al.
Publicado: (2015)

Investigating the two regimes of fibrin clot lysis: an experimental and computational approach
por: Raynaud, Franck, et al.
Publicado: (2021)

Citrullinated Fibrinogen Renders Clots Mechanically Less Stable, but Lysis-Resistant
por: Varjú, Imre, et al.
Publicado: (2021)

Comparison of clot lysis activity and biochemical properties of originator tenecteplase (Metalyse(®)) with those of an alleged biosimilar
por: Kliche, Werner, et al.
Publicado: (2014)

Effect of Nonionic Surfactants (Dodecyl Maltoside and Polysorbate 20) on Prevention of Aggregation and Conformational Changes of Recombinant Human IFNβ_1b Induced by Light
por: Mahjoubi, Najmeh, et al.
Publicado: (2017)

Thrombin‐generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause
por: Hofer, Stefanie, et al.
Publicado: (2019)

In Vitro Whole Blood Clot Lysis for Fibrinolytic Activity Study Using D-Dimer and Confocal Microscopy
por: Elnager, Abuzar, et al.
Publicado: (2014)

Reteplase: Structure, Function, and Production
por: Mohammadi, Elmira, et al.
Publicado: (2019)

Factors influencing lysis time stochasticity in bacteriophage λ
por: Dennehy, John J, et al.
Publicado: (2011)

Mathematical Modelling of Intravenous Thrombolysis in Acute Ischaemic stroke: Effects of Dose Regimens on Levels of Fibrinolytic Proteins and Clot Lysis Time
por: Gu, Boram, et al.
Publicado: (2019)

The Efficacy of Fibrinogen Concentrates in Relation to Cryoprecipitate in Restoring Clot Integrity and Stability against Lysis
por: Whyte, Claire S., et al.
Publicado: (2022)

Clot waveform of APTT has abnormal patterns in subjects with COVID-19
por: Shimura, Takuya, et al.
Publicado: (2021)

FTIR Investigation of Secondary Structure of Reteplase Inclusion Bodies Produced in Escherichia coli in Terms of Urea Concentration
por: Naeimipour, Sajjad, et al.
Publicado: (2020)

EspP, an Extracellular Serine Protease from Enterohemorrhagic E. coli, Reduces Coagulation Factor Activities, Reduces Clot Strength, and Promotes Clot Lysis
por: Kuo, Kevin H. M., et al.
Publicado: (2016)

The Effect of Sugammadex on Prothrombin and Activated Partial Thromboplastin Time
por: Samara, Evangelia, et al.
Publicado: (2021)

Hyperglycemia Is Associated With Enhanced Thrombin Formation, Platelet Activation, and Fibrin Clot Resistance to Lysis in Patients With Acute Coronary Syndrome
por: Undas, Anetta, et al.
Publicado: (2008)

Development and Validation of a Micellar Capillary Electrophoresis Method for Determination of IFNβ-1b in Lyophilized Formulation of a Biosimilar Product
por: Dadgarnejad, Manuchehr, et al.
Publicado: (2015)

TESTING OPTIMALITY WITH EXPERIMENTAL EVOLUTION: LYSIS TIME IN A BACTERIOPHAGE
por: Heineman, Richard H, et al.
Publicado: (2007)

Platelet rich clots are resistant to lysis by thrombolytic therapy in a rat model of embolic stroke
por: Tomkins, Amelia J, et al.
Publicado: (2015)

Improving the solubility, activity, and stability of reteplase using in silico design of new variants
por: Ghaheh, Hooria Seyedhosseini, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sb3r92fn2oambkpeuo59qvq4v4